Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors-Reference-Cited by-同舟云学术

Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors

Published:2018-08 Issue: Volume:58 Page:78-85
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Papachristopoulou Georgia,Tsapralis Nikolaos^ORCID,Michaelidou Kleita,Ardavanis-Loukeris Gerasimos,Griniatsos Ioannis,Scorilas Andreas,Talieri Maroulio

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference40 articles.

1. Management of breast fibroadenomas;Greenberg;J. Gen. Intern. Med.,1998

2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

3. Benign breast disease and the risk of breast cancer;Hartmann;N. Engl. J. Med.,2005

4. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis;Dyrstad;Breast Cancer Res. Treat.,2015

5. Atypical hyperplasia of the breast—risk assessment and management options;Hartmann;N. Engl. J. Med.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker;International Journal of Molecular Sciences;2023-05-08

2. KLK12 Regulates MMP-1 and MMP-9 via Bradykinin Receptors: Biomarkers for Differentiating Latent and Active Bovine Tuberculosis;International Journal of Molecular Sciences;2022-10-14

3. The evolution and ecology of benign tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-01

4. LACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S‑1;Oncology Letters;2021-04-13

5. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo;Materials Science and Engineering: C;2020-05